Episode Details

Psychedelic retreats gain traction, offering mental healing through substances like magic mushrooms and ayahuasca. Despite Trumps order to speed up FDA reviews, these retreats mostly operate illegally in the US. Experts warn of risks, highlighting gaps in screening, prep, and follow-up care. A study found that over half screen out those with schizophrenia, and nearly ninety percent advise stopping antidepressants beforehand. Safety remains a concern as regulations lag behind.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/ec575ad823746431